Medical expert of the article
New publications
Preparations
Paclinor
Last reviewed: 09.08.2022
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Paclinor is an antitumor medication, a plant-derived cytotoxic.
Among its synonyms are such drugs: paclitaxel actavis, taxol, paclitaxel, paclitaxel ebeve, paclitax, paxen, paclal, paclitaxel-teva, paclitera, docetaxel, mitotax, sindaksel, taxakad, and others.
Manufacturer Paklinor - the company Marksans Pharma Ltd (India).
The active substance of this drug is paclitaxel, obtained from taxanes (alkaloids of the short-leaved yew bark), indications for use. Paclinor, form of release, as well as pharmacodynamics. Paklinor and pharmacokinetics of Paclinor completely coincide with the drug, manufactured under another trade name - Paclitaxel Actavis.
Also identical to the drug Paclitaxel Actavis contraindications to the use of Paclinor, side effects, method of administration and dose, overdose, interaction of Paclinor with other drugs, etc.
Attention!
To simplify the perception of information, this instruction for use of the drug "Paclinor" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.
Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.